Current issues regarding treatment of mitochondrial fatty acid oxidation disorders

Journal of Inherited Metabolic Disease

Volumn 33, Issue 5, 2010, Pages 555-561

  Spiekerkoetter, Ute ^f   Bastin, Jean ^b   Gillingham, Melanie ^c   Morris, Andrew ^d   Wijburg, Frits ^e   Wilcken, Bridget ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CNRS   (France)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d ST MARY S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; BEZAFIBRATE; CARNITINE; DOCOSAHEXAENOIC ACID; FATTY ACID DERIVATIVE; LONG CHAIN FATTY ACID; MEDIUM CHAIN TRIACYLGLYCEROL; MITOCHONDRIAL PROTEIN; TRIHEPATANOIN; UNCLASSIFIED DRUG;

CARNITINE PALMITOYLTRANSFERASE 2 DEFICIENCY; CHORIORETINOPATHY; CLINICAL EVALUATION; CLINICAL TRIAL; DIET SUPPLEMENTATION; DISEASE COURSE; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DRUG USE; ENERGY; ENZYME DEFICIENCY; EXERCISE; FATTY ACID OXIDATION DEFECT; HUMAN; LIPID DIET; LIPID STORAGE; LONG CHAIN ACYL COENZYME A DEHYDROGENASE DEFICIENCY; LOW FAT DIET; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE DEFICIENCY; MYOPATHY; NEWBORN SCREENING; NONHUMAN; PATHOPHYSIOLOGY; PATIENT IDENTIFICATION; PHYSICAL ACTIVITY; RETINA; REVIEW; SPORT; VERY LONG CHAIN ACYL COENZYME A DEHYDROGENASE DEFICIENCY; VISUAL ACUITY;

ENERGY METABOLISM; EVIDENCE-BASED MEDICINE; FATTY ACIDS; GENOTYPE; HUMANS; LIPID METABOLISM, INBORN ERRORS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; OXIDATION-REDUCTION; PHENOTYPE; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 77957574072     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-010-9188-1     Document Type: Review

References (39)

1. C Agostoni N Massetto G Biasucci, et al. 2000 Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia J Pediatr 137 504 509 1:CAS:528:DC%2BD3cXotV2itrc%3D 10.1067/mpd.2000.108398 11035829
2. JP Bonnefont J Bastin A Behin F Djouadi 2009 Bezafibrate for an inborn mitochondrial beta-oxidation defect N Engl J Med 360 838 840 1:CAS:528:DC%2BD1MXitFGnur8%3D 10.1056/NEJMc0806334 19228633
3. PB Corr MH Creer KA Yamada JE Saffitz BE Sobel 1989 Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation J Clin Invest 83 927 936 1:CAS:528:DyaL1MXhs1Grs7k%3D 10.1172/JCI113978 2921326
4. KB Cox J Liu L Tian S Barnes Q Yang PA Wood 2009 Cardiac hypertrophy in mice with long-chain acyl-CoA dehydrogenase or very long-chain acyl-CoA dehydrogenase deficiency Lab Invest 89 1348 1354 1:CAS:528:DC%2BD1MXhsVGrtL3L 10.1038/labinvest.2009.86 19736549
5. F Djouadi JP Bonnefont L Thuillier, et al. 2003 Correction of fatty acid oxidation in carnitine palmitoyl transferase 2-deficient cultured skin fibroblasts by bezafibrate Pediatr Res 54 446 451 1:CAS:528:DC%2BD3sXntlejs70%3D 10.1203/01.PDR.0000083001.91588.BB 12840153 (Pubitemid 37159110)
6. F Djouadi F Aubey D Schlemmer, et al. 2005 Peroxisome proliferator activated receptor delta (PPAR{delta}) agonist but not PPAR{alpha} corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells J Clin Endocrinol Metab 90 1791 1797 1:CAS:528:DC%2BD2MXisVOhur4%3D 10.1210/jc.2004-1936 15613406 (Pubitemid 40464053)
7. KT Fahnehjelm G Holmstrom L Ying, et al. 2008 Ocular characteristics in 10 children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a cross-sectional study with long-term follow-up Acta Ophthalmol 86 329 337 10.1111/j.1600-0420.2007.01121.x 18162058 (Pubitemid 351790218)
8. MB Gillingham WE Connor D Matern, et al. 2003 Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency Mol Genet Metab 79 114 123 1:CAS:528:DC%2BD3sXksVGlt7s%3D 10.1016/S1096-7192(03)00073-8 12809642 (Pubitemid 36693930)
9. MB Gillingham RG Weleber M Neuringer, et al. 2005 Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency Mol Genet Metab 86 124 133 1:CAS:528:DC%2BD2MXhtVOksLnJ 10.1016/j.ymgme.2005.06.001 16040264 (Pubitemid 41412168)
10. MB Gillingham B Scott D Elliott CO Harding 2006 Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency Mol Genet Metab 89 58 63 1:CAS:528:DC%2BD28XotlCjsL0%3D 10.1016/j.ymgme.2006.06.004 16876451 (Pubitemid 44205484)
11. S Gobin-Limballe F Djouadi F Aubey, et al. 2007 Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotype-based therapy Am J Hum Genet 81 1133 1143 1:CAS:528:DC%2BD2sXhtl2jurfF 10.1086/522375 17999356 (Pubitemid 350211445)
12. H Herrema TG Derks TH van Dijk, et al. 2008 Disturbed hepatic carbohydrate management during high metabolic demand in medium-chain acyl-CoA dehydrogenase (MCAD)-deficient mice Hepatology 47 1894 1904 1:CAS:528: DC%2BD1cXotVagtrs%3D 10.1002/hep.22284 18459129 (Pubitemid 351945557)
13. DR Hoffman R Uauy 1992 Essentiality of dietary omega 3 fatty acids for premature infants: plasma and red blood cell fatty acid composition Lipids 27 886 895 1:CAS:528:DyaK3sXitFGjsg%3D%3D 10.1007/BF02535868 1362792
14. HH Huidenkoper J Schneider T Westphal PM Vaz M Duran FA Wijburg 2006 Prolonged moderate-intensity excercise without and with L-carnitine supplementation in patients with MCAD deficiency J Inherit Metab Dis 29 631 636 10.1007/s10545-006-0355-3 (Pubitemid 44390425)
15. SM Innis DH Adamkin RT Hall, et al. 2002 Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula J Pediatr 140 547 554 1:CAS:528:DC%2BD38Xlt1Cltbo%3D 10.1067/mpd.2002.123282 12032520 (Pubitemid 34666724)
16. AE Jeukendrup WH Saris AJ Wagenmakers 1998 Fat metabolism during exercise: a review-part II: regulation of metabolism and the effects of training Int J Sports Med 19 293 302 1:CAS:528:DyaK1cXltFKmsLo%3D 10.1055/s-2007-971921 9721051
17. PJ Lee EL Harrison MG Jones S Jones JV Leonard RA Chalmers 2005 L-carnitine and exercise tolerance in medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency: a pilot study J Inherit Metab Dis 28 141 152 1:CAS:528:DC%2BD2MXjvFKqsbk%3D 10.1007/s10545-005-5262-5 15877203 (Pubitemid 40723882)
18. AM Lund F Joensen DM Hougaard, et al. 2007 Carnitine transporter and holocarboxylase synthetase deficiencies in The Faroe Islands J Inherit Metab Dis 30 341 349 1:STN:280:DC%2BD2szntVagtA%3D%3D 10.1007/s10545-007-0527-9 17417720
19. EM Maier J Pongratz AC Muntau, et al. 2009 Validation of MCADD newborn screening Clin Genet 76 179 187 1:CAS:528:DC%2BD1MXhtlKis7vN 10.1111/j.1399-0004.2009.01217.x 19780764
20. Nasser M, Javaheri H, Fedorowicz Z, Noorani Z. (2009) Carnitine supplementation for inborn errors of metabolism. Cochrane database Syst Rev. 15: CD006659
21. S Primassin F Ter Veld E Mayatepek U Spiekerkoetter 2008 Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine Pediatr Res 63 632 637 1:CAS:528:DC%2BD1cXlslGqtbs%3D 10.1203/PDR. 0b013e31816ff6f0 18317232
22. CR Roe L Sweetman DS Roe F David H Brunengraber 2002 Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride J Clin Invest 110 259 269 1:CAS:528:DC%2BD38XlsVGltr4%3D 12122118
23. CR Roe BZ Yang H Brunengraber DS Roe M Wallace BK Garritson 2008 Carnitine palmitoyltransferase II deficiency: successful anaplerotoc diet therapy Neurology 71 260 264 1:CAS:528:DC%2BD1cXosFSku7Y%3D 10.1212/01.wnl. 0000318283.42961.e9 18645163
24. JP SanGiovanni CS Berkey JT Dwyer GA Colditz 2000 Dietary essential fatty acids, long-chain polyunsaturated fatty acids, and visual resolution acuity in healthy fullterm infants: a systematic review Early Hum Dev 57 165 188 1:CAS:528:DC%2BD3cXitVSrsr4%3D 10.1016/S0378-3782(00)00050-5 10742608 (Pubitemid 30160763)
25. AM Schuler PA Wood 2002 Mouse models for disorders of mitochondrial fatty acid beta-oxidation ILAR J 43 57 65 1:CAS:528:DC%2BD38XntFGgsL4%3D 11917157
26. U Spiekerkoetter B Sun T Zytkovicz R Wanders AW Strauss U Wendel 2003 MS/MS-based newborn and family screening detects asymptomatic patients with very-long-chain acyl-CoA dehydrogenase deficiency J Pediatr 43 335 342
27. U Spiekerkoetter B Sun T Zytkovicz R Wanders AW Strauss U Wendel 2003 MS/MS-based newborn and family screening detects asymptomatic patients with very long-chain acyl-CoA dehydrogenase deficiency J Pediatr 143 335 342 10.1067/S0022-3476(03)00292-0 14517516 (Pubitemid 37188318)
28. U Spiekerkoetter T Tenenbaum A Heusch U Wendel 2003 Cardiomyopathy and pericardial effusion in infancy point to a fatty acid b-oxidation defect after exclusion of an underlying infection Pediatr Cardiol 24 295 297 1:STN:280:DC%2BD3s3mt12mtQ%3D%3D 10.1007/s00246-002-0277-2 12457256 (Pubitemid 36920019)
29. U Spiekerkoetter Z Khuchua Z Yue MJ Bennett AW Strauss 2004 General mitochondrial trifunctional protein (TFP) deficiency as a result of either alpha- or beta-subunit mutations exhibits similar phenotypes because mutations in either subunit alter TFP complex expression and subunit turnover Pediatr Res 55 190 196 1:CAS:528:DC%2BD2cXjsl2ltQ%3D%3D 10.1203/01.PDR.0000103931.80055.06 14630990 (Pubitemid 38120994)
30. U Spiekerkoetter Z Khuchua Z Yue AW Strauss 2004 The early-onset phenotype of mitochondrial trifunctional protein deficiency: a lethal disorder with multiple tissue involvement J Inherit Metab Dis 27 294 296 1:CAS:528:DC%2BD2cXkt1Sqtrs%3D 10.1023/B:BOLI.0000028839.57386.88 (Pubitemid 38756349)
31. U Spiekerkoetter C Tokunaga U Wendel, et al. 2005 Tissue carnitine homeostasis in very-long-chain acyl-CoA dehydrogenase-deficient mice Pediatr Res 57 760 764 1:CAS:528:DC%2BD2MXkt1aiur0%3D 10.1203/01.PDR.0000157915.26049.47 15774826 (Pubitemid 40727102)
32. U Spiekerkoetter M Mueller E Cloppenburg, et al. 2008 Intrauterine cardiomyopathy and cardiac mitochondrial proliferation in mitochondrial trifunctional protein (TFP) deficiency Mol Genet Metab 94 428 430 1:CAS:528:DC%2BD1cXosVOntbY%3D 10.1016/j.ymgme.2008.04.002 18485779
33. U Spiekerkoetter M Lindner R Santer, et al. 2009 Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop J Inherit Metab Dis 32 488 497 1:STN:280:DC%2BD1MrkslSluw%3D%3D 10.1007/s10545-009-1125-9 19399638
34. U Spiekerkoetter M Lindner R Santer, et al. 2009 Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop J Inherit Metab Dis 32 498 505 1:STN:280:DC%2BD1MrkslWnug%3D%3D 10.1007/s10545-009-1126-8 19452263
35. A Tenenbaum M Motro EZ Fisman 2005 Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons Cardiovasc Diabetol 4 14 19 10.1186/1475-2840-4-14 16168052 (Pubitemid 41461006)
36. JH Walter 2005 L-carnitine in inborn errors of metabolism: what is the evidence? J Inherit Metab Dis 26 2-3 181 188
37. RJA Wanders P Vreken MEJ Den Boer, et al. 1999 Disorders of mitochondrial fatty acyl-CoA β-oxidation J Inherit Metab Dis 22 442 487 1:CAS:528:DyaK1MXkslOmtL4%3D 10.1023/A:1005504223140 10407780 (Pubitemid 29281036)
38. B Wilcken M Haas P Joy, et al. 2007 Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study Lancet 369 37 42 1:CAS:528:DC%2BD2sXit12itw%3D%3D 10.1016/S0140-6736(07)60029-4 17208640 (Pubitemid 46027226)
39. SC Winter 2003 Treatment of carnitine deficiency J Inherit Metab Dis 26 171 180 1:CAS:528:DC%2BD3sXkvVCku7s%3D 10.1023/A:1024433100257 12889658